David H. Lawson MD


Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 35

  1. 1
  2. 2
  3. 3
  4. 4


Relationship between Physician-Adjudicated Adverse Events and Patient-Reported Health-Related Quality of Life in a Phase II Clinical Trial (NCT01143402) of Patients with Metastatic Uveal Melanoma

by Thomas M Atkinson; Jennifer L. Hay; Alexander Shoushtari; Yuelin Li; Daniel J. Paucar; Sloane C. Smith; Ragini R. Kudchadkar; Austin Doyle; Jeffrey Sosman; Jorge Fernando Quevedo; Mohammed M. Milhem; Anthony M. Joshua; Gerald P. Linette; Thomas F. Gajewski; Jose Lutzky; David H Lawson; Christopher Lao; Patrick J. Flynn; Mark R. Albertini; Takami Sato; Karl Lewis; Brian Marr; David Abramson; Mark Andrew Dickson; Gary Schwartz; Richard Carvajal



Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

by Jonathan S. Zager; Brian R. Gastman; Sancy Leachman; Rene C. Gonzalez; Martin D. Fleming; Laura K. Ferris; Jonhan Ho; Alexander R. Miller; Robert W. Cook; Kyle R. Covington; Kristen Meldi-Plasseraud; Brooke Middlebrook; Lewis H. Kaminester; Anthony Greisinger; Sarah I. Estrada; David M. Pariser; Lee D. Cranmer; Jane L. Messina; John T. Vetto; Jeffrey D. Wayne; Keith A Delman; David H Lawson; Pedram Gerami



Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth

by Siyuan Xia; Ruiting Lin; Lingtao Jin; Liang Zhao; Hee-Bum Kang; Yaozhu Pan; Shuangping Liu; Guoging Qian; Zhiyu Qian; Evmorfia Konstantakou; Baotong Zhang; Jin-Tang Dong; Young Rock Chung; Omar Abdel-Wahab; Taha Merghoub; Lu Zhou; Ragini R. Kudchadkar; David H Lawson; H Jean Khoury; Fadlo Khuri; Lawrence Boise; Sagar Lonial; Benjamin H. Lee; Brian P Pollack; Jack Arbiser; Jun Fan; Qun-Ying Lei; Jing Chen



Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma.

by Asim Amin; David Lawson; April K.S. Salama; Henry B. Koon; Troy Guthrie; Sajeve S. Thomas; Steven J. O'Day; Montaser F. Shaheen; Bin Zhang; Stephen Francis; F. Stephen Hodi